Barriers to Eye Screening for People With Diabetes in India

Status Completed

Clinical Trial Summary

Brief Summary: Diabetic retinopathy (DR) is a leading cause of visual impairment and has major public health implications globally and especially in countries such as India where the prevalence of diabetes is high. With timely screening and intervention, the disease progression to blindness can be prevented but several barriers exist to the provision of care. The long term aim is to identify the barriers to DR screening and to plan potential interventional strategies. From the qualitative study, the reasons such as lack of awareness or knowledge, distance to travel, lack of reminder system were identified as a reason for poor follow-up. This lead to the development of interventional strategies.

This was a randomized, investigator-masked clinical trial that was conducted in a tertiary eye care centre in South India. Consecutive patients with diabetes who were residents in Chennai and its vicinity of approximately 100 km radius and who were undergoing repeated intravitreal injections for DME were recruited into the trial. The aim of the study is to investigate the effect of SMS informational reminders among patients with Diabetic macular edema for the follow-up. They study consists of 2 groups, SMS reminder group receives the reminders 1 week and 2 days prior to the scheduled appointments with the concerned doctor on a particular date and time, whereas other group does not receive any reminders for the appointment schedule. After the follow-up, the patients will be screened for the attendance at the review visit.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04544553
Study type	Interventional
Source	Lions Club International Foundation
Contact
Status	Completed
Phase	N/A
Start date	January 24, 2019
Completion date	August 14, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03953807` - A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated	Phase 4
Completed	`NCT03622580` - A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)	Phase 3
Recruiting	`NCT06262737` - Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol
Terminated	`NCT04603937` - A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)	Phase 3
Terminated	`NCT04611152` - A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)	Phase 3
Active, not recruiting	`NCT04108156` - This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab	Phase 3
Completed	`NCT02867735` - A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema	Phase 1
Withdrawn	`NCT03629210` - Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema	Phase 2
Withdrawn	`NCT02842541` - Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema	Phase 1
Completed	`NCT02221453` - Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide	Phase 2
Completed	`NCT02979665` - Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema
Completed	`NCT02556723` - Intravitreal Injections of Ziv-aflibercept for Macular Diseases	N/A
Completed	`NCT02000102` - Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab	N/A
Completed	`NCT02088229` - Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema	N/A
Terminated	`NCT00779142` - Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies	N/A
Completed	`NCT01171976` - Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus	Phase 3
Completed	`NCT00989989` - Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema	Phase 3
Completed	`NCT00683176` - Effect of Choline Fenofibrate (SLV348) on Macular Edema	Phase 2
Completed	`NCT01259609` - Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy	N/A
Terminated	`NCT00768040` - Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema	Phase 2